TP73 and cancer: For instance, p73-activating drugs might be effective only in case of cancer cells expressing the “right” isoforms of p73 (i.e. TA-p73) and in designing new strategies it would be important to develop specific drugs, or RNA-based therapeutics, that can modulate the relative expression of ΔN-p73 and TA-p73 isoforms.